WHV Investments’s Novartis NVS Stock Holding History

WHV Investments’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$3.06M	Sell	47,112 -1,195,098	-96%	-$81.3M	1.64%	26
2015 Q4	$95.8M	Sell	1,242,210 -547,269	-31%	-$43.5M	4.23%	9
2015 Q3	$153M	Sell	1,789,479 -231,060	-11%	-$20.6M	4.23%	11
2015 Q2	$178M	Sell	2,020,539 -223,301	-10%	-$20.5M	3.99%	12
2015 Q1	$198M	Sell	2,243,840 -244,036	-10%	-$21.6M	3.89%	13
2014 Q4	$207M	Sell	2,487,876 -115,001	-4%	-$9.53M	3.54%	13
2014 Q3	$220M	Sell	2,602,877 -27,345	-1%	-$2.21M	3.13%	14
2014 Q2	$213M	Sell	2,630,222 -88,929	-3%	-$6.99M	2.69%	17
2014 Q1	$207M	Sell	2,719,151 -306,058	-10%	-$22.3M	2.72%	18
2013 Q4	$218M	Sell	3,025,209 -276,985	-8%	-$19.3M	2.27%	17
2013 Q3	$227M	Sell	3,302,194 -120,286	-4%	-$7.96M	2.25%	18
2013 Q2	$217M	Buy	+3,422,480	New	+$223M	2.23%	20

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Institutional Capital Chicago, Illinois $6.75B AUM 3.44% 1-Year Est. Return

WHV Investments's NVS Position: Q1 2016 in Review

WHV Investments reduced its Novartis (NVS) stake by 96% in Q1 2016, selling an estimated $81.3M and leaving 47,112 shares worth $3.06M. The position accounts for 1.64% of the portfolio, ranked #26.

WHV Investments first reported a position in NVS in Q2 2013 and has held it in 12 quarters since. The position peaked at $227M in Q3 2013. 876 funds tracked by Wall St. Rank hold NVS as of Q1 2016.

WHV Investments held 47,112 shares of Novartis worth $3.06M as of Q1 2016.
WHV Investments sold 1,195,098 Novartis shares in Q1 2016, an estimated $81.3M.
Novartis made up 1.64% of WHV Investments's portfolio in Q1 2016, its #26 holding.
WHV Investments first reported a position in Novartis in Q2 2013 and has held it in 12 quarters since.
WHV Investments's Novartis position peaked at $227M in Q3 2013.
876 funds tracked by Wall St. Rank held Novartis as of Q1 2016.

Based on WHV Investments's 13F filing for Q1 2016, filed 11 May 2016.